v3.26.1
Summary of Significant Accounting Policies (Tables)
 6 Months Ended
Jun. 30, 2026
Accounting Policies [Abstract]  
Schedule of Unrealized Gain (Loss) on Investments
The following tables present the Company’s restricted cash equivalents and restricted investments as of June 30, 2026 and December 31, 2025, respectively.
June 30, 2026
Amortized Cost BasisGross Unrealized GainsGross Unrealized LossesFair Value
Money market funds$543,480 $— $— $543,480 
Corporate bonds746,141 257 (1,175)745,223 
U.S. government obligations21,600,785 387 (51,663)21,549,509 
Total$22,890,406 $644 $(52,838)$22,838,212 
Included in restricted cash and cash equivalents$6,937,745 $17 $(16)$6,937,746 
Included in restricted investments$15,952,661 $627 $(52,822)$15,900,466 
December 31, 2025
Amortized Cost BasisGross Unrealized GainsGross Unrealized LossesFair Value
Money market funds$161,983 $— $— $161,983 
Corporate bonds939,157 6,832 — 945,989 
U.S. government obligations16,102,457 102,064 (497)16,204,024 
Total$17,203,597 $108,896 $(497)$17,311,996 
Included in restricted cash and cash equivalents$1,465,903 $218 $— $1,466,121 
Included in restricted investments$15,737,694 $108,678 $(497)$15,845,875 
Schedule of Investments Classified by Contractual Maturity Date
The following table summarizes the contractual maturities of the Company’s restricted cash equivalents and restricted investments as of June 30, 2026 and December 31, 2025, respectively:
June 30, 2026December 31, 2025
Amortized CostFair ValueAmortized CostFair Value
Within 1 year$15,633,846 $15,631,244 $6,760,198 $6,762,886 
After 1 year through 5 years2,739,500 2,721,731 6,118,800 6,159,400 
After 5 years through 10 years4,517,060 4,485,237 4,324,599 4,389,710 
Total$22,890,406 $22,838,212 $17,203,597 $17,311,996 
Schedule of Estimated Useful Lives A summary of estimated useful lives is as follows:
Estimated Useful Life
Buildings39 years
Office equipment and furniture
3-7 years
Vehicles
5-8 years
Medical and other plant equipment5 years
Leasehold improvementsShorter of useful life of asset or lease term
Schedule of Disaggregation of Revenue
In the following table, revenues are disaggregated as follows:
Revenue BreakdownThree Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Primary Geographical Markets
U.S.$60,430,620 $66,258,565 $123,169,860 $148,232,981 
U.K.12,994,099 14,159,057 25,805,343 28,217,696 
Total revenues$73,424,719 $80,417,622 $148,975,203 $176,450,677 
Major Segments
Mobile Health Services$21,417,771 $30,780,993 $45,043,018 $75,990,537 
Transportation Services52,006,948 49,636,629 103,932,185 100,460,140 
Total revenues$73,424,719 $80,417,622 $148,975,203 $176,450,677 
Schedule of Earnings Per Share, Basic and Diluted
The following table presents the calculation of basic and diluted net loss per share to stockholders of DocGo Inc. and Subsidiaries:
Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Net loss attributable to stockholders of DocGo Inc. and Subsidiaries$(15,820,277)$(11,155,246)(30,583,408)(20,560,561)
Weighted-average shares outstanding - Basic98,802,810 98,931,293 98,774,609 100,255,877 
Effect of dilutive options— — — — 
Weighted-average shares outstanding - Diluted98,802,810 98,931,293 98,774,609 100,255,877 
Net loss per share attributable to DocGo Inc. and Subsidiaries - Basic$(0.16)$(0.11)(0.31)(0.21)
Net loss per share attributable to DocGo Inc. and Subsidiaries - Diluted$(0.16)$(0.11)(0.31)(0.21)
Anti-dilutive employee share-based awards excluded16,472,812 13,339,305 16,472,812 13,339,305